Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
about
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsIn vitro and in vivo cytotoxicity of troglitazone in pancreatic cancerNew derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study.Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsOvercoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axisKCa 3.1-a microglial target ready for drug repurposing?Exploiting drug repositioning and the brain microenvironment to treat brain metastases.Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug.Drug repurposing: In-vitro anti-glycation properties of 18 common drugs.Repositioning of proton pump inhibitors in cancer therapy.Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.Immune Cell Metabolism in Tumor Microenvironment.Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression.Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects.Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials.Drug Repositioning for Effective Prostate Cancer Treatment.Metformin as a Therapeutic Target in Endometrial CancersEffects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsInhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityDrug Repurposing of Metabolic Agents in Malignant GliomaOnline structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets
P2860
Q28066756-13B0B681-B210-4C2A-92A0-A1AAF3AEED54Q32174263-BF550BEC-B8DB-43CE-9C9A-B7220641C3E1Q37237139-BC9188F5-3AC8-4F25-B8AE-422E043A2B12Q37437614-F4AA71BB-F1D5-4447-94BC-ACCD68ECAEAAQ37687338-0E280229-7ED3-4FE1-B947-971B94F19043Q38819263-F8321407-6289-421C-AEB7-E24A7576DCECQ42944473-380BCBAF-647A-4CF4-A303-E92803991384Q47136172-A7ACD0A0-BE37-4665-8022-161E8C18C6D2Q47232839-E6A4E987-5502-4F28-B2B1-C8EC3C687272Q48142620-CAFA42EB-2F8F-44D0-A2C1-33CC1C11B714Q48675205-B352820E-2CCD-475A-A55B-98CC29D9136CQ50217783-740FBAE5-8B83-44A7-9158-A295F3C9DF32Q52626741-E6650C4B-143F-45F9-9E6A-612CCD7D62BEQ52676408-111FDF0B-204F-491B-8543-B4022B14677CQ55103799-460872FC-9F7F-4C3E-89DB-5D9594A34070Q55254671-10CD528C-7D03-46C2-B55A-2F460D7D200FQ58698115-1306E55D-2B9C-4442-9DB6-43840B574EE8Q58706536-A052FD7D-D2B9-461A-9257-8CBEF7FD7520Q58728819-377D2C9F-9FB2-4A36-B634-F81E8C3B9CD4Q58738611-9D3F2081-B608-43DF-AC49-E8B3502AA64BQ58767948-0097EFE2-6A27-4201-9A83-0825D0CECD48
P2860
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Drug-repositioning opportuniti ...... r targets for known compounds.
@en
type
label
Drug-repositioning opportuniti ...... r targets for known compounds.
@en
prefLabel
Drug-repositioning opportuniti ...... r targets for known compounds.
@en
P50
P1433
P1476
Drug-repositioning opportuniti ...... r targets for known compounds.
@en
P2093
Adriana Bajetto
Stefano Thellung
P304
P356
10.1016/J.DRUDIS.2015.09.017
P577
2015-10-05T00:00:00Z